This page shows the latest VBP news and features for those working in and with pharma, biotech and healthcare.
The value-based procurement (VBP) process in China will cover all insulins supplied in hospitals and is expected to be implemented in the first half of 2022.
always meant to be a stop-gap measure while the UK developed a value-based pricing (VBP) scheme for medicines. ... The failure of the VBP initiative has meant that the CDF has extended much longer than originally anticipated and it has careened over
VBP however failed to be approved and the issues around access from 2010 remain today; politically it has also proved difficult for the government to remove this Fund as it has
At that point in the negotiations the government was still looking to heavily rely on a brand new value-based pricing (VBP) approach to assessing new medicine costs – a method that ... Several months after Sir Andrew's meeting a new PPRS plan was
as value-based pricing (VBP), would overcome the market access problems that saw NICE reject so many of these drugs. ... VBP died a long, slow death in 2013 however and was replaced with a similar system to that used for over 50 years in the UK, meaning
The Fund was initially meant to last for three years until the introduction of value-based pricing (VBP) in the UK.
More from news
Approximately 7 fully matching, plus 26 partially matching documents found.
of a new drug pricing system, known as value-based pricing (VBP). ... VBP however failed to be approved and the issues around access from 2010 remain today; politically it has also proved difficult for the government to remove this Fund as it has
Finally, there is the spectre of a new drug pricing policy in the guise of value-based pricing (VBP) that is due to come into effect at the start of 2014. ... With VBP, though still an unknown quantity for pharma and, perhaps just as worryingly, the
The new chair of the UK’s NICE discusses navigating the stormy waters of health service reforms, collaborating with pharma and the introduction of VBP. ... Little is known about what this will entail, however, although it has been confirmed that NICE
We are concerned about the implications of the value-based pricing (VBP) system of reimbursement that the government wants to implement from 2014, because as an investor, one of the things
For example, the UK plans to introduce Value-based Pricing (VBP) for NCEs in 2014, based on a range of cost-effectiveness thresholds, which in turn are based on disease burden, ... We need'parametric' VBP, variable over time. However, there is little
More from intelligence
Approximately 0 fully matching, plus 6 partially matching documents found.
We focus on what matters most…. Driven by insight, expertise and fresh thinking, our award-winning communications programmes are designed to...